Chitogenx Inc News Today

ChitogenX Inc (CSE:CHGX, OTCQB:CHNXF) told investors that its proprietary chitosan/platelet-rich plasma (PRP)-based biopolymer matrix, ORTHO-R, has...

ChitogenX Inc (CSE:CHGX, OTCQB:CHNXF) told investors it has launched a new development program targeting significant unmet medical needs in the...

ChitogenX Inc (CSE:CHGX, OTCQB:CHNXF) told investors that it made significant progress in deleveraging its balance sheet and improving its working capital...

ChitogenX Inc (CSE:CHGX, OTCQB:CHNXF) told investors it has received a notice of allowance for a key patent in the US and Canada. The companys shares rose...

ChitogenX Inc (CSE:CHGX, OTCQB:CHNXF) said it has concluded the enrolment of 20 subjects in its US multi-site rotator cuff tear repair Phase I/II clinical...

ChitogenX Inc (CSE:CHGX, OTCQB:CHNXF) said it has concluded the enrolment of 20 subjects in its US multi-site rotator cuff tear repair Phase I/II clinical...

Monday U.S. Featured Earnings THOR Industries, Inc. (NYSE:THO) (Q4) Reported EPS of 96 cents compared to $5.15 in the prior-year quarter. DZS Inc. (NASDAQ:DZSI) (Q2) Reported EPS for 15 cents, compared to 17 cents in the prior-year quarter. ...

Monday U.S. Featured Earnings THOR Industries, Inc. (NYSE:THO) (Q4) Reported EPS of 96 cents compared to $5.15 in the prior-year quarter. DZS Inc. (NASDAQ:DZSI) (Q2) Reported EPS for 15 cents, compared to 17 cents in the prior-year quarter. ...

Patient recruitment for our Rotator cuff repair Phase I/II trial reached important milestone ORTHO-R soft-tissue residency properties confirmed in...

Successful completion of initial portion of U.S. Phase I/II ORTHO-R rotator cuff tear repair clinical trial Phil Deschamps and Jonathan Sackier M.D. hired as...